This study is testing a new way to treat soft tissue sarcoma (a type of cancer that grows in soft tissues like muscle or fat) in your arm, leg, or trunk (chest, abdomen, and pelvis). It uses a shorter course of radiation therapy called Hypofractionated Radiation Therapy (HFRT) given over 5 days before surgery. The goal is to treat the cancer and prevent it from spreading, while also protecting healthy tissue. Researchers will be looking at how safe HFRT is and any early side effects. You may be able to join if you are 18 or older, have a confirmed soft tissue sarcoma in an arm, leg, or trunk, and are healthy enough for radiation and surgery. This study plans to enroll 40 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 40 participants.

What's involved

Active participation in the study will involve about 12 visits. These visits are completed once you have a 6-month post-operation visit.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, HFRT Safety, is measured at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.